Inventor · disambiguated record
Tia Marie Ditommaso
Also filed as: DITOMMASO TIA · DITOMMASO TIA M · DITOMMASO TIA MARIE
7 granted patents·24 pending applications·6 citations·filing 2017–2023
77Inventor score
Top patents by PatentIndex Score
31 records- 0195US11453867B2CRISPR DNA targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2021·Granted Sep 27, 2022·4 cites·23 claims
- 0293US11976308B2CRISPR DNA targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted May 7, 2024·1 cites·23 claims
- 0392US11795442B2CRISPR DNA targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Oct 24, 2023·1 cites·23 claims
- 0484US2024101990A1Crispr dna targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2023·Application pending·0 cites
- 0575US11866746B2Compositions comprising a variant Cas12i4 polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Jan 9, 2024·0 cites·20 claims
- 0673US12460190B2CRISPR DNA targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2020·Granted Nov 4, 2025·0 cites·25 claims
- 0772US11821012B2Gene editing systems comprising an RNA guide targeting hydroxyacid oxidase 1 (HAO1) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Nov 21, 2023·0 cites·22 claims
- 0868US11939607B2Gene editing systems comprising an RNA guide targeting lactate dehydrogenase a (LDHA) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Mar 26, 2024·0 cites·21 claims
- 0966US2023097861A1Intracellular delivery of complexesSQZ BIOTECHNOLOGIES CO·Filed 2022·Application pending·0 cites
- 1065US2025127924A1Gene editing systems comprising an rna guide targeting stathmin 2 (stmn2) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1165US2024254494A1Gene editing systems comprising an rna guide targeting hydroxyacid oxidase 1 (hao1) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1265US2023032141A1Gene editing systems comprising an rna guide targeting hydroxyacid oxidase 1 (hao1) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1365US2023203539A1Gene editing systems comprising an rna guide targeting stathmin 2 (stmn2) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1463US2024309346A1Compositions comprising a variant cas12i4 polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1561US2022396782A1Gene editing systems comprising an rna guide targeting transthyretin (ttr) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1661US2024261435A1Gene editing systems comprising an rna guide targeting transthyretin (ttr) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1760US2024093228A1Compositions comprising a nuclease and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1858US2024011031A1Compositions comprising a nuclease and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 1957US2023034581A1Gene editing systems comprising an rna guide targeting lactate dehydrogenase a (ldha) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 2055US2023193243A1Compositions comprising a cas12i2 polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2154US2022372456A1Novel crispr dna targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 2254US2024368632A1Cells modified by a cas12i polypeptideARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 2353US2023407343A1Compositions comprising an rna guide targeting pdcd1 and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2453US2023416732A1Compositions comprising an rna guide targeting bcl11a and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2553US2023235305A1Cells modified by a cas12i polypeptideARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2653US2023399639A1Compositions comprising an rna guide targeting b2m and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2752US2023045187A1Compositions comprising a nuclease and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 2851US2022282283A1Novel crispr dna targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 2951US2023332119A1Compositions comprising a cas12i2 variant polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 3051US2023016656A1Novel crispr dna targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 3146US2019017072A1Intracellular delivery of complexesSQZ BIOTECHNOLOGIES CO·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tia Marie Ditommaso files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →